|
|
|
|
| LEADER |
01767nam a2200253 u 4500 |
| 001 |
EB001839762 |
| 003 |
EBX01000000000000001003751 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
180702 r ||| eng |
| 245 |
0 |
0 |
|a Medicare national coverage determinations
|h Elektronische Ressource
|
| 260 |
|
|
|a Baltimore (MD)
|b Centers for Medicare & Medicaid Services (US)
|c 2009, 2009
|
| 300 |
|
|
|a 1 online resource
|
| 653 |
|
|
|a Insurance Coverage / statistics & numerical data
|
| 653 |
|
|
|a Needs Assessment
|
| 653 |
|
|
|a United States
|
| 653 |
|
|
|a Medicare
|
| 710 |
2 |
|
|a Centers for Medicare & Medicaid Services (U.S.)
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 500 |
|
|
|a Title from HTML title screen
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK299387
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a Medicare coverage is limited to items and services that are reasonable and necessary for the diagnosis or treatment of an illness or injury (and within the scope of a Medicare benefit category). National coverage determinations (NCDs) are made through an evidence-based process, with opportunities for public participation. In some cases, CMS' own research is supplemented by an outside technology assessment and/or consultation with the Medicare Evidence Development & Coverage Advisory Committee (MEDCAC). In the absence of a national coverage policy, an item or service may be covered at the discretion of the Medicare contractors based on a local coverage determination (LCD). The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 amended several portions of the NCD development process with an effective date of January 1, 2004
|